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Abstract
Background: Medication nonadherence can compound into severe medical problems for patients. Identifying patients who are
likely to become nonadherent may help reduce these problems. Data-driven machine learning models can predict medication
adherence by using selected indicators from patients’ past health records. Sources of data for these models traditionally fall under
two main categories: (1) proprietary data from insurance claims, pharmacy prescriptions, or electronic medical records and (2)
survey data collected from representative groups of patients. Models developed using these data sources often are limited because
they are proprietary, subject to high cost, have limited scalability, or lack timely accessibility. These limitations suggest that social
health forums might be an alternate source of data for adherence prediction. Indeed, these data are accessible, affordable, timely,
and available at scale. However, they can be inaccurate.
Objective: This paper proposes a medication adherence machine learning model for fibromyalgia therapies that can mitigate
the inaccuracy of social health forum data.
Methods: Transfer learning is a machine learning technique that allows knowledge acquired from one dataset to be transferred
to another dataset. In this study, predictive adherence models for the target disease were first developed by using accurate but
limited survey data. These models were then used to predict medication adherence from health social forum data. Random forest,
an ensemble machine learning technique, was used to develop the predictive models. This transfer learning methodology is
demonstrated in this study by examining data from the Medical Expenditure Panel Survey and the PatientsLikeMe social health
forum.
Results: When the models are carefully designed, less than a 5% difference in accuracy is observed between the Medical
Expenditure Panel Survey and the PatientsLikeMe medication adherence predictions for fibromyalgia treatments. This design
must take into consideration the mapping between the predictors and the outcomes in the two datasets.
Conclusions: This study exemplifies the potential and limitations of transfer learning in medication adherence–predictive models
based on survey data and social health forum data. The proposed approach can make timely medication adherence monitoring
cost-effective and widely accessible. Additional investigation is needed to improve the robustness of the approach and extend its
applicability to other therapies and other sources of data.
(JMIR Med Inform 2019;7(2):e12561)   doi:10.2196/12561
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Introduction
Medication nonadherence is one of the most expensive medical
expenditures. As of 2015, the cost of patient nonadherence in
the United States reached US $290 billion [1]. The majority of
the cost of nonadherence arises from prescriptions that are either
never filled or medications that are not taken as prescribed [2].
Although the financial losses are staggering, the most prominent
motivation for better adherence is saving patients whose
conditions worsen due to poor compliance. Indeed, close to
125,000 deaths related to inadequate adherence were reported
in the United States [3].
Identifying patients at risk and the reasons for medication
nonadherence can help guide the development of remedial and
preventive plans. For many years, researchers have stipulated
that several factors can influence nonadherence including poor
patient-doctor interactions and a lack of overall health
understanding [3]. On one hand, the multitude of factors and
their potential interdependence make profiling patients at risk
of nonadherence difficult [3,4]. On the other hand, the
digitization efforts in the health sector over the past decade have
resulted in the availability of various data sources that can
support the design of medication adherence–prediction models.
Examples of such sources include reimbursement claims data
from insurance companies, dispensed medication data from
pharmacies, and medication prescription data from health
providers. Using these proprietary data, several recent
medication adherence–predictive models were developed and
deployed. For instance, Express Scripts developed a model with
300 predictors [5]. These predictors include the patient’s
demographic as well as clinical and genomic indicators. The
Express Scripts model was reported to have a prediction
accuracy of over 90% with a lead time of 6-12 months. Similar
proprietary models were also developed by Allazo Health and
FICO [6,7].
These models, although successful, primarily rely on proprietary
data accessible to the health provider. These data tend to be
structured and relatively accurate, providing models with high
predictive accuracy [5]. However, the proprietary nature of both
the data and the predictive models hinders their widespread use
by other health service providers. Due to these limitations,
several research efforts started to explore the use of data from
social media for large-scale analysis of trends in population
health. For instance, social media data were used to build a
machine learning model that can predict stress [8]. Twitter data
were used to study allergen effects and monitor adverse events
of pharmaceutical products across the United States [9,10].
Social media was also used as a mechanism for engaging
patients in order to improve compliance [11,12] and assist
nonadherent patients [13]. Recently, a medication-adherence
model using Twitter was proposed by Klein et al [14]. This
model identifies the medication intake from tweets that mention
at least one of 55 different medications.
The abovementioned studies highlight the fact that
medication-adherence models, in particular, and population
health models, in general, have been progressing along parallel
but completely disjointed paths. The first path draws its
advantage from the accuracy and validity of the data collected
in a controlled environment at the expense of limited
applicability to the wider population, whereas the second path
leverages widespread accessibility, but suffers from reduced
data accuracy or lack of verifiable model validity. The objective
of this paper is to answer the question: Can machine learning
models trained using data from a controlled environment be
used to predict medication adherence for health social forum
users? If they can be used, this approach can bridge the
abovementioned parallel paths and help combine the benefits
of the two environments.
In machine learning, transfer learning is used to improve
modeling in various domains including social media data
[15,16,17]. This technique is similar to the ability of a human
to transfer knowledge from one context to another, thereby
reducing the learning efforts required with every new context.
This approach has not been previously explored for medication
adherence. The aim of this paper is to investigate the
applicability of this approach to medication adherence among
patients with fibromyalgia. Fibromyalgia was selected to
demonstrate the proposed approach because of its high incidence
rate and the fact that it is subject to strict medication regimens
with severe consequences of nonadherence [18]. The proposed
medication-adherence models for this disease are trained using
the Medical Expenditure Panel Survey (MEPS) dataset [19].
Although it is not proprietary, the MEPS dataset is used in this
paper as a proxy for datasets collected in a controlled
environment. The target domain for knowledge transfer is the
social health forum PatientsLikeMe [20]. This paper investigates
the accuracy of MEPS-trained models when used to predict the
adherence of PatientsLikeMe users in the case of fibromyalgia.
The mapping between the variables in the source and target
datasets and its impact on the prediction accuracy of the
proposed models are also analyzed.
Methods
The Machine Learning Model
Typically, a machine learning model is an agent trained with a
set of predictors to generate a target outcome. This model varies
based on the dataset used for the training and validation as well
as the technique used to train each model. Moreover,
traditionally, each model is trained and validated using data
from a single source, since the learning and application are
confined to a single domain. In this paper, and because we are
learning from one domain and applying this knowledge to a
different domain, two datasets are needed. These datasets are
derived from MEPS and PatientsLikeMe.
Data Extraction and Cross-Domain Variable Mapping
The MEPS database is provided by the Agency for Healthcare
Research and Quality [19]. It is a collection of surveys from a
nationally representative population of individuals. The survey
participants provide responses in a series of five rounds over a
2-year interval. During each round, participants are asked to
answer a survey questionnaire that focuses on their health status,
medical conditions, prescribed medications, and insurance
coverage. Each year, a new panel of participants is enrolled in
the study, while the previous year’s panel finishes the final
JMIR Med Inform 2019 | vol. 7 | iss. 2 | e12561 | p.2http://medinform.jmir.org/2019/2/e12561/
(page number not for citation purposes)
Haas et alJMIR MEDICAL INFORMATICS
XSL•FO
RenderX
second year. This panel overlap provides an insight into
nationwide dynamic changes. For the purpose of this study,
patient records were extracted from panels 17-19, which span
the period from 2012 to 2015.
The second data source is PatientsLikeMe, which is a social
health forum where patients post, discuss, and review many of
their current medications and conditions [20]. Some of the users
of this forum make their data publicly available. The data were
collected from treatment evaluations as of March 2017. These
evaluations are available in a structured format that includes
self-reported adherence to treatment.
Patients from MEPS and PatientsLikeMe were selected if they
were receiving a treatment associated with the target disease
fibromyalgia. Treatments were included in the list if they were
taken by at least a single patient from PatientsLikeMe. This list
includes duloxetine, gabapentin, pregabalin, tramadol, and
zolpidem.
The model predictors that were extracted for each patient from
both data sources are type of medication, years taking treatment,
daily intake, dosage, age at the end of the study or last known
age, sex of the patient, out-of-pocket expense, and region of
living of the patient (ie, Northeast, Midwest, West, or South).
These were the only predictors available in both MEPS and
PatientsLikeMe.
As previously mentioned, typical machine learning models rely
on a dataset from a single domain for training and validation.
However, because we want to transfer knowledge from one
domain to another, mapping is needed from the variables in the
source dataset to their counterpart in the target dataset. This
mapping is straightforward (ie, one to one) in the case of the
first six predictors (ie, type of medication, years taking
treatment, daily intake, dosage, age, and sex).
However, more elaborate mapping was needed for out-of-pocket
expense and region of living. Although MEPS provides the
exact amount paid for each medication, PatientsLikeMe lists
only ranges for the approximate expenses each month.
Therefore, out-of-pocket expense payments in MEPS were
categorized using the out-of-pocket expense ranges provided
in PatientsLikeMe (Table 1). Similarly, the residence of each
MEPS patient is provided according to the appropriate US
census region, while for PatientsLikeMe, the residence of the
patient is provided at the state level. Again, since one-to-one
mapping between the two datasets is needed for knowledge
transfer, the value of region of living for PatientsLikeMe was
mapped to the census region based on the state of residence of
the patient (eg, Indiana is mapped to the Midwest).
Table 1. Categorical ranges for out-of-pocket expenses.
Out-of-pocket expense categoryActual expenses (US $)
0<25
125-50
250-100
3100
4>200
The mapping for the out-of-pocket expense and region of living
predictors between the two datasets is relatively simple. The
challenge is mapping the outcome of the model. The target
outcome for the model is medication adherence. In
PatientsLikeMe, patients self-report a selected adherence value
from four categories (ie, Always taken as prescribed, Usually
taken as prescribed, Sometimes taken as prescribed, or Never
taken as prescribed). The MEPS data do not include a direct
measure of adherence; therefore, this measure had to be derived.
In a previous study, Hess et al evaluated 11 different
medication-adherence metrics and recommended the use of
medication-refill adherence (MRA), which is defined as the
total number of days of medication supply divided by the
number of days of study participation multiplied by 100 [21].
For example, a patient with a total of 200 days of supply over
a period of 365 days will have an MRA of 55%.
The MRA value from MEPS and the adherence classes from
PatientsLikeMe have to be mapped to a common scale. This
scale consists of two classes: adherent and nonadherent. For
PatientsLikeMe, the Always taken as prescribed category is
mapped to the adherent class and the remaining three categories
(ie, Usually taken as prescribed, Sometimes taken as prescribed,
and Never taken as prescribed) are mapped to the nonadherent
class. In the case of MEPS, four different MRA thresholds are
considered. For each threshold, if the MRA is greater than or
equal to the threshold value, the outcome is mapped to the
adherent class; otherwise, the outcome is mapped to the
nonadherent class. The threshold is varied in order to understand
the differences in the interpretation of adherence between the
MEPS and the PatientsLikeMe datasets. This difference can be
due to the fact that adherence is quantitative in MEPS and
qualitative in PatientsLikeMe. Moreover, using MRA as an
adherence measure in MEPS does not account for scenarios
where patients are proactive in refilling their prescriptions or
accidentally misplace medications. Finally, adherence in
PatientsLikeMe is self-reported and may therefore be subjective
[22]. Understanding the differences between the variables in
the two datasets and calibrating the associated mapping is a
necessary enabler for transfer learning.
Model Training and Validation
The model proposed for prediction of medication adherence is
based on the random forest (RF) tool [23]. Other machine
learning techniques (eg, neural networks and support
vector machine) are available [24,25]. Although models based
on these techniques can be considered for medication adherence,
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RF was selected for this study because (1) it can handle variables
with missing and categorical values, a characteristic inherent
to social forum data [23]; (2) it facilitates the comparative
analysis of two models trained by using different datasets
including the evaluation of the importance of each predictor in
each model [26], which is needed for the validation of transfer
learning; and (3) it was successfully used in previous
health-related models including models to predict the response
of patients to various drugs and models to predict patients with
liver disease [27,28]. Previous studies [27,28] showed that RF
outperformed other machine learning techniques including
neural networks and support vector machine.
RF consists of an ensemble of decision trees, where each tree
contributes a vote to the overall decision of the RF. A majority
vote of adherent or nonadherent classifies the patient as adherent
or nonadherent, respectively. The uniqueness of each tree is
ensured through a two-step randomization process. The first
step is called bagging or bootstrap aggregation and is responsible
for randomizing the patients [29]. For each tree in the RF, a
predefined number of patients are selected randomly from the
training dataset with replacement. Based on this selection, a
given patient may be selected more than once in a given tree,
while other patients may not be selected. The second
randomization step selects predictors and occurs during the
construction of each tree. Only a random subset of the predictors
is considered at each node. In this paper, the size of this subset
was set to a typical standard of Standalone Equation 1, where
n is the total number of predictors in the dataset. Randomized
selection of both patients and predictors from the training dataset
helps generate multiple unique decision trees in the RF
ensemble.
The best predictor among the Standalone Equation 1 predictors
considered at each node of the decision tree is selected based
on the greatest reduction in impurity [30]. The parent node in
the tree always has a higher impurity (less homogenous set of
patients) than its children. A homogenous set of patients
corresponds to the case where all the patients belong to the same
class (ie, adherent class or nonadherent class). The impurity of
a node is defined by I=1-(A+)
2–(A–)
2, where A+ and A– are the
percentage of adherent and nonadherent patients, respectively,
presented to the node in a given tree [30]. The change in
impurity between the parent node (p) and its left (l) and right
(r) child nodes is given by ΔI= Ip– PlIl– PrIr, where Pl and Pr
represent the percent of the total number of patients in the parent
node that are mapped to the left and right branches, respectively.
In order to split the patients into the appropriate right or left
branches at each node, the selected predictor requires a reference
value. All possible values for a given predictor are iteratively
evaluated until the best split is found (ie, branches with the
lowest impurity). In general, predictors can be numeric or
categorical. For instance, the predictor age is numeric. When
age is used as a predictor for a given node in the tree, patients
with an age value greater than the reference value are assigned
to the right branch of the node, and the remaining patients are
assigned to the left branch. For the categorical predictors, such
as region of living, patients that have the same value as the
reference value are assigned to the right branch, while the
remaining patients are assigned to the left branch.
The abovementioned procedure describes the traditional learning
process used for decision trees [23]. One of the limitations of
this process is that it does not adequately handle patients with
missing predictor values. As previously mentioned, missing
predictor values are prevalent in social media data. Specifically,
in the PatientsLikeMe dataset, 40% of the patients with
fibromyalgia had at least one missing predictor value. Several
approaches can be considered to handle missing predictor values:
(1) A default split can be adopted, where the patient with a
missing predictor value is arbitrarily yet consistently assigned
to a given branch. (2) The corresponding patient record can be
removed. (3) All numeric predictors are binned using k-means
clustering [27]. An additional bin is then added to represent the
case where the predictor value is missing.
All of the abovementioned approaches were investigated and
discarded because of their limitations. The default split is
arbitrary and leads to poor accuracy. The second approach
excludes approximately half of the patients from
PatientsLikeMe. The third approach translates all numerical
values to categorical values. In order to overcome the limitations
of these previous approaches, a new technique for learning with
missing values in RF models is proposed.
Traditional RF models use decision trees that are binary trees,
where each node has one left and one right child. The proposed
model uses ternary decisions trees, where each node has three
children: a left child, a middle child, and a right child. Patients
with missing predictor values are assigned to the third child.
The underlying learning algorithm is modified in order to
accommodate the additional child and to ensure that the missing
value is never selected as a reference in the split at any node.
RF models for fibromyalgia are trained using the
abovementioned approach. The training dataset is composed of
patient records that include the predictors and the target outcome
(ie, adherent/nonadherent). It is also balanced and consists of
an equal number of adherent/nonadherent patients. This class
balance eliminates the potential of bias in the model toward the
larger represented class. The model is then validated using a
testing dataset that is completely independent from the training
dataset. Two metrics are used to quantify this validation: (1)
Accuracy: The ratio of the number of records that are correctly
predicted to the total number of records in the testing dataset
and (2) F1 score: A composite metric that represents a weighted
balance between the recall and the precision of the models.
Recall accounts for the number of correctly classified adherent
patients compared with the total number of actually adherent
patients in the testing dataset. Precision is the total number of
correctly classified adherent patients against the total number
of patients classified as adherent.
Another measure is used to evaluate the importance of each
predictor in the model. Predictor importance (PI) is defined as
the ratio of the number of times a predictor is traversed to the
total number of times all the predictors are traversed in the RF
model when processing the testing dataset. As described earlier,
the decision trees in the RF model are built by selecting
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predictors that provide the greatest reduction in impurity.
Although there are measures to ensure that the same predictor
is not selected repeatedly at each node, the number of times a
predictor is selected is indicative of its relative entropy compared
to other predictors. Therefore, the higher the PI, the more
important the predictor is in the model.
Transfer Learning
In an ideal case, a model trained on MEPS patients should be
able to predict medication adherence for patients from
PatientsLikeMe with the same level of accuracy. As an analogy,
a human trained to drive a given vehicle should be able to
transfer this knowledge to the driving of a different vehicle.
However, transferring this knowledge is not simple in either
case. The success of this transfer is subject to disparities in
data-collection methods, variable mapping, and population
distribution between the source and target domains.
Despite the abovementioned difficulties, transfer learning offers
several benefits. For instance, the approach has been used to
transfer user behavior and content knowledge from one social
network to another [15,16]. The approach has also been used
for the predictive modeling of the relationship between
transcription factor-binding sites and gene expression from one
human cell line to another [17]. Transfer learning can help relax
the accuracy requirements that are often associated with
traditional machine learning methods [31]. Specifically, it can
make a medication-adherence model that is developed and
validated in a controlled environment accessible to a large-size
population with a limited financial burden through, for example,
social health forum services. In general, the proposed approach
exemplifies the transfer of health models from the proprietary
domain to the public domain.
Working toward this objective, a medication-adherence model
was initially trained on MEPS patients using all the predictors
extracted from the dataset. It was then tested on both the MEPS
and the PatientsLikeMe patients. Ideally, the model should be
able to predict medication adherence for both population groups
with the same level of accuracy. However, this transfer was
dependent on the adequacy of the mapping between the
predictors and the outcomes in the two domains. This aspect is
particularly important in this study owing to the absence of an
absolute ground truth for medication adherence and the fact that
adherence is equated to medication refills in MEPS and to a
subjective self-reported assessment by the patient in
PatientsLikeMe.
In order to understand the potential and limitation of transfer
learning for medication adherence between MEPS and
PatientsLikeMe, the following procedure was adopted:
• The prediction accuracy results for both domains were
compared. A significant difference in the accuracy between
the two domains is indicative of predictors that fail to
transfer from the source domain (MEPS) to the target
domain (PatientsLikeMe).
• A secondary model was developed by using the target
domain dataset (in this case, PatientsLikeMe). The purpose
of this model is to provide an understanding of the
differences in the importance of each predictor across the
two domains.
• Guided by the abovementioned analysis and using a
reductionist approach, a set of predictors that do not transfer
from MEPS to PatientsLikeMe was removed.
• A revised model was then developed with the remaining
set of predictors, which are deemed transferrable between
the two domains. The transfer capabilities of the revised
model were then re-evaluated using both the MEPS and the
PatientsLikeMe datasets.
Results
Overview
The findings derived from the application of the methodology
described in the previous section are presented below. These
results highlight the salient characteristics of the datasets, the
predictive accuracy of the model developed by using the
traditional machine learning approach, and the potential
applicability of this model to a different domain when
appropriate transfer learning requirements are taken into
consideration.
Data Extraction and Cross-Domain Variable Mapping
The demographic breakdown of the MEPS and PatientsLikeMe
cohorts is shown in Table 2. The average PatientsLikeMe patient
was about 10 years younger than the average MEPS patient.
With respect to the region of residence, the largest difference
was observed in the southern region. The MEPS patient
population in this region accounted for approximately 40% of
the total population. However, the PatientsLikeMe dataset had
a southern patient population that barely exceeded 30%.
Moreover, compared to male patients, female patients accounted
for the majority of the cohort for both datasets. However, the
female population was significantly larger in the PatientsLikeMe
(91%) dataset compared to the MEPS (63.9%) dataset.
In addition to understanding the differences in the demographic
distribution of the patients across the two domains, an
understanding of the distribution of the patients into
adherent/nonadherent classes is crucial. As previously
mentioned, the MEPS dataset does not contain a direct adherence
metric. Therefore, based on previous studies [21], adherence
was derived from the MRA. Since the MRA threshold that
distinguishes between adherent/nonadherent patients is not
known a priori, several values (ie, 35%, 45%, 65%, and 80%)
for the threshold were considered. The distribution of the
adherent/nonadherent MEPS patients for each threshold is shown
in Table 3. PatientsLikeMe patients self-reported adherence
(adherent: n=281 [79%]; nonadherent: n=76 [21%]).
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Table 2. Demographics of MEPSa and PatientsLikeMe patients with fibromyalgia.
PatientsLikeMe patients (N=357)MEPS patients (N=3044)Characteristic
49.1 (10.7)58.0 (14.9)Age (years), mean (SD)
Sex, n (%)
27 (7.6)995 (32.7)Male
325 (91.0)1945 (63.9)Female
5 (1.4)103 (3.4)Unknown
Region, n (%)
55 (15.4)399 (13.1)Northeast
84 (23.5)651 (21.4)Midwest
110 (30.8)1309 (43.0)South
92 (25.8)560 (18.4)West
16 (4.5)125 (4.1)Unknown
aMEPS: Medical Expenditure Panel Survey
Table 3. Distribution of adherent and nonadherent Medical Expenditure Panel Survey patients for varying medication refill–adherence thresholds.
Nonadherent patients, n (%)Adherent patients, n (%)MRAa threshold (%)
2330 (77)714 (23)80
2138 (70)906 (30)65
1730 (57)1314 (43)45
1473 (48)1571 (52)35
aMRA: medication-refill adherence.
Model Training and Validation
Models for fibromyalgia were trained and tested using the MEPS
dataset at different MRA threshold values. For each model, the
dataset was split into a training and a testing dataset following
an 80/20 split. Moreover, patients were randomly removed from
the higher represented class in each training dataset until a 50/50
balance between adherent and nonadherent patients was
obtained. For instance, 1616 nonadherent patients selected at
random were removed from the model at the 80% MRA
threshold.
The results in Table 4 show that the highest predictive accuracy
was obtained when the MRA threshold was set to 35%. This
indicates that the MEPS models are better at differentiating
between extremely nonadherent patients and moderately or
highly adherent patients. Based on this result, the MRA
threshold of 35% was adopted in the remainder of the study.
An intended direction for future work is investigating multiclass
adherence models that can differentiate between highly and
moderately adherent patients.
Transfer Learning
The MEPS fibromyalgia model developed in the previous
section was tested using the PatientsLikeMe dataset. The
prediction accuracy for this dataset was 54.9%, which is
significantly lower than the accuracy obtained with the MEPS
dataset (76.2%; Table 4). This significant difference indicates
that some of the predictors did not adequately transfer from
MEPS to PatientsLikeMe. To investigate this result, the PI
values for the predictors in the MEPS model were compared to
the PI values for the predictors of a secondary model that was
trained using the PatientsLikeMe dataset (Table 5).
Predictors with large differences in PI values across the two
domains suggest that a predictor has a higher significance in
one domain than in the other domain. Based on the results of
Table 5, the PI values of both daily intake and out-of-pocket
expense differ by approximately 4% across the two domains,
while none of the other predictors show a difference of more
than ~1%.
Guided by this result, a reduced MEPS model was created after
the elimination of the two predictors daily intake and
out-of-pocket expense. The performance of the reduced model
for both testing datasets (ie, MEPS and PatientsLikeMe) is
reported in Table 6. Removing the two predictors significantly
improved the accuracy and the F1 score for the PatientsLikeMe
dataset. As expected, however, for the MEPS testing dataset, a
slight reduction in accuracy was observed in the reduced model
as compared to the original model. Typically, in traditional
machine learning methods, more predictors yield higher
accuracy models. However, for transfer learning, these predictors
must also map adequately from the source domain to the target
domain.
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Table 4. Accuracy and F1 scores of fibromyalgia medication-prediction models that were trained and tested using the Medical Expenditure Panel
Survey dataset. Models were created for varying medication refill–adherence thresholds.
F1 scoreModel accuracy (%)Patients in the testing
dataset, n (%)
Patients in the training
dataset, n (%)
MRAa threshold (%)
72.570.2285 (20)1143 (80)80
70.069.9362 (20)1450 (80)65
74.673.0525 (20)2103 (80)45
77.176.2609 (20)2436 (80)35
aMRA: medication-refill adherence.
Table 5. Predictor importance for each predictor in the MEPSa–trained model and the PatientsLikeMe-trained model. Both models were tested using
the MEPS dataset.
Predictor importancePredictor
Model trained by PatientsLikeMeModel trained by MEPS
24.724.2Type of medication
12.511.9Years taking treatment
5.311.8Daily intake
14.414.4Dosage
13.69.7Out-of-pocket expense
9.68.5Region of living of the patient
16.115.2Age at the end of the study or last known age
3.84.3Sex of the patient
aMEPS: Medical Expenditure Panel Survey.
Table 6. Accuracy and F1 score of the reduced MEPS
a–trained model for the MEPS and PatientsLikeMe testing datasets. For comparison, the second
row category of the table repeats the results previously obtained for the original model with all predictors from Table 4.
PatientsLikeMe datasetMEPS datasetModel
Reduced model (without daily intake and out-of-pocket expense)
67.873.2Accuracy (%)
79.773.9F1 score
Original model (with daily intake and >out-of-pocket expense)
54.976.2Accuracy (%)
65.577.1F1 score
aMEPS: Medical Expenditure Panel Survey.
Additional investigation is needed to analyze why some of the
predictors transfer, whereas others do not. We speculate that
some of the root causes can be attributed to potential
over/underreporting by the patients [22] and to differences in
the sociodemographic distribution of the patients. For instance,
80% of the MEPS patients had an out-of-pocket expense <US
$25 each month, whereas less than 40% of the patients in
PatientsLikeMe reported an out-of-pocket expense <US $25.
Discussion
Principal Results
This study shows that it is possible to develop and validate a
model for fibromyalgia medication adherence in a controlled
environment and then apply it widely through social health
forums. A model trained using MEPS patients with fibromyalgia
was able to predict adherence with an accuracy of 73.2% and
an F1 score of 73.9 for other MEPS patients. Traditionally, for
this model to benefit a wider population of patients, these
patients would have to be enrolled in the MEPS survey, an
approach that is neither practical nor cost-effective. This paper
shows that the MEPS model can be transferred to the social
health forum PatientsLikeMe with careful mapping between
the variables in each domain. The proposed approach was tested
with PatientsLikeMe patients with fibromyalgia, and the
MEPS-trained model was able to predict adherence for these
patients with an accuracy of 67.8% and an F1 score of 79.7.
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Limitations
An initial design of the model showed that two of the predictors
(daily intake and out-of-pocket expense) in MEPS failed to
adequately transfer to PatientsLikeMe. Additional investigation
is needed to understand the root cause of this lack of transfer.
Access to additional demographic information about the patients
may help with this investigation. However, information
including race, education, and social status was not available
in this study. Furthermore, although MRA was previously shown
to provide a good estimate of adherence, there are certain cases
where this threshold could misclassify a patient as adherent,
since there are no assurances that the medication is actually
being taken by the patient.
Future Work
Future work will consider transfer learning in the context of
multiclass adherence models (ie, always, usually, sometimes,
or never taken as prescribed). In addition, we would like to
study transfer learning for other diseases and other datasets
including other social media sources. Finally, understanding
the impact of missing values, an unavoidable characteristic of
social media data, and development of learning techniques that
can handle missing values are areas open for continued research.
Conclusions
The transferability of a model developed and validated in a
controlled environment to the wider public provides tremendous
possibilities for improved population health. One can imagine
a model for medication adherence derived by a health institution
deployed in PatientsLikeMe and enabling the users of this forum
to receive alerts or targeted educational material when they are
flagged to be at risk of nonadherence.
Transfer learning from one domain to another can be extended,
perhaps to disease prediction or other health-related models.
This research showed that robust models that can systematically
transfer from one domain to another are possible and that it is
important to understand the limitations of this transfer. We
showed that transfer learning between MEPS and
PatientsLikeMe produced similar accuracy of
medication-adherence prediction. This approach can have a
significant advantage, even if this advantage comes at a slight
reduction in prediction accuracy compared with costly,
institution-specific machine learning models.
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